tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PepGen Faces FDA Partial Hold Amid Ongoing FREEDOM2 Trial
PremiumCompany AnnouncementsPepGen Faces FDA Partial Hold Amid Ongoing FREEDOM2 Trial
3d ago
PepGen announce FDA placed partial clinical hold on Phase 2 trial of PGN-EDODM1
Premium
The Fly
PepGen announce FDA placed partial clinical hold on Phase 2 trial of PGN-EDODM1
3d ago
PepGen reports Q4 EPS (27c), consensus (39c)
Premium
The Fly
PepGen reports Q4 EPS (27c), consensus (39c)
3d ago
PepGen Buy Rating: De-Risked Safety and Potential Category-Leading Efficacy for PGN-EDODM1 in DM1 Ahead of 1Q26 MAD Readout
PremiumRatingsPepGen Buy Rating: De-Risked Safety and Potential Category-Leading Efficacy for PGN-EDODM1 in DM1 Ahead of 1Q26 MAD Readout
2M ago
PepGen Inc. Appoints New Chief Business Officer
Premium
Company Announcements
PepGen Inc. Appoints New Chief Business Officer
3M ago
PepGen appoints Joseph Vittiglio as chief business, legal officer
Premium
The Fly
PepGen appoints Joseph Vittiglio as chief business, legal officer
3M ago
PepGen Inc. Reprices Underwater Stock Options
PremiumCompany AnnouncementsPepGen Inc. Reprices Underwater Stock Options
4M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
4M ago
PepGen price target raised to $18 from $12 at H.C. Wainwright
Premium
The Fly
PepGen price target raised to $18 from $12 at H.C. Wainwright
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100